Interchange Capital Partners’s Quest Diagnostics DGX Stock Holding History

Interchange Capital Partners’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,742	Closed	-$302K	–	351
2025 Q4	$302K	Buy	1,742 +585	+51%	+$107K	0.06%	299
2025 Q3	$220K	Buy	+1,157	New	+$205K	0.04%	323
2023 Q2	–	Sell	-2,041	Closed	-$286K	–	164
2023 Q1	$286K	Sell	2,041 -327	-14%	-$46.8K	0.16%	149
2022 Q4	$370K	Sell	2,368 -885	-27%	-$127K	0.38%	62
2022 Q3	$399K	Sell	3,253 -599	-16%	-$78.9K	0.44%	64
2022 Q2	$512K	Buy	3,852 +137	+4%	+$18.7K	0.58%	48
2022 Q1	$508K	Buy	3,715 +1,590	+75%	+$222K	0.52%	59
2021 Q4	$367K	Buy	+2,125	New	+$323K	0.37%	93
2021 Q1	–	Sell	-22	Closed	-$2K	–	438
2020 Q4	$2K	Buy	+22	New	+$2.68K	﹤0.01%	1073

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Interchange Capital Partners's DGX Position: Q1 2026 in Review

Interchange Capital Partners sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 1,742 shares — an estimated $302K sold.

Interchange Capital Partners first reported a position in DGX in Q4 2020 and held it in 9 quarters. The position peaked at $512K in Q2 2022. 1,067 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Interchange Capital Partners reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
Interchange Capital Partners sold 1,742 Quest Diagnostics shares in Q1 2026, an estimated $302K.
Interchange Capital Partners first reported a position in Quest Diagnostics in Q4 2020 and held it in 9 quarters.
Interchange Capital Partners's Quest Diagnostics position peaked at $512K in Q2 2022.
1,067 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Interchange Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.